Loading...
•
Mar 31
Adtalem Q3 2025 Earnings Report
Reported third quarter fiscal year 2025 results with revenue up 12.9% and diluted EPS of $1.59, raising full-year guidance.
Key Takeaways
Adtalem Global Education reported strong third quarter fiscal year 2025 results, with significant growth in revenue and earnings per share, driven by increased student enrollment across its institutions. The company also raised its full-year guidance, reflecting continued positive momentum.
Total student enrollment increased by 9.8% year-over-year, reaching 94,223.
Revenue grew by 12.9% year-over-year to $466.1 million.
Diluted earnings per share was $1.59, with adjusted EPS at $1.92, a 28.0% increase year-over-year.
The company completed a $300 million share repurchase program and authorized a new $150 million program.
Adtalem
Adtalem
Adtalem Revenue by Segment
Revenue by Segment
Chamberlain Revenue
CapyFin.comWalden Revenue
CapyFin.comMedical and Veterinary Revenue
CapyFin.com Forward Guidance
Adtalem raised its fiscal year 2025 guidance for both revenue and adjusted earnings per share, reflecting confidence in continued growth.
Positive Outlook
- Revenue guidance increased to a range of $1,760 million to $1,775 million, representing approximately 11% to 12% growth year-over-year.
- Adjusted earnings per share guidance increased to a range of $6.40 to $6.60, representing approximately 28% to 32% growth year-over-year.
- Continued momentum from seven consecutive quarters of enrollment growth is expected.
- Investments in innovative programs are anticipated to meet rising demand for healthcare professionals.
- The new $150 million share repurchase program through May 2028 demonstrates a commitment to returning value to shareholders.
Challenges Ahead
- No specific negative forward guidance points were provided in the report.